Gene delivery system capable of demixing cell membrane coating and its preparation method and application
A technology of gene delivery and cell membrane, which is applied in gene therapy, medical preparations of non-active ingredients, capsule delivery, etc., can solve the problems of nanocomposite internalized drug release obstacles, etc., to prolong blood circulation time, promote interaction, The effect of improving serum stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] Prepare the cationic polypeptide material, as follows:
[0058] First, the ring-opening polymerization of five-membered ring N-carboxyanhydride (NCA) was initiated by hexamethyldisilane (HMDS), and a polypeptide (polyγ-propargyl-L- Glutamic acid, PPLG), and the molecular weight of PPLG was characterized by gel chromatography (GPC) ( figure 1 ). Then in the glove box, PPLG (20 mg, 0.06 mmol), guanidinium small molecule azide N 3 -HG (85 mol%, 0.204 mmol), small molecule azide compound containing benzene ring (15 mol%, 0.036 mmol), pentamethyldiethylenetriamine (PMDETA, 126 μL, 0.604 mmol) were dissolved in dimethyl Formamide (DMF, 4 mL), then copper bromide (CuBr, 0.12 mmol, 17.56 mg) was added. After stirring the reaction at room temperature for 48 h, hydrochloric acid solution (1 M, 1 mL) was added, dialyzed in deionized water for 3 days (MWCO = 3.5 kDa), and the product was obtained as a white solid after freeze-drying. 400 M H NMR spectrum ( 1 H NMR) to characte...
Embodiment 2
[0068] Polypeptide P-Ben (1 mg / mL) and siRNA (0.1 μg / mL) were dissolved in DEPC water, mixed according to the mass ratio of P-Ben / siRNA to 15, and incubated at room temperature for 30 min to form a binary nanocomposite Object P-Ben / siRNA (BS). PLL-CA (2 mg / mL) was dissolved in DEPC water (pH = 8, adjusted with sodium hydroxide), added to the BS complex solution according to the mass ratio of PLL-CA / P-Ben as 2, 5, and 10, and mixed well , incubated at room temperature for 30 min to form a ternary nanocomplex PLL-CA / P-Ben / siRNA (BSPC), with Figure 6 structure shown.
Embodiment 3
[0070] The mixed membrane solution (HM) of Example 1 was added to the BSPC complex solution of Example 2 according to the mass ratio of cell membrane / PLL-CA of 0.2, and then ultrasonicated for 3 min (ultrasonic frequency 40 kHz) to obtain detachable mixed cell membrane packets The gene delivery system (BSPC@HM), with Figure 7 In the structure shown, the mass ratio of cell membrane, polymer material, cationic polypeptide and drug is 15:75:15:1.
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com